(Q33846578)

29 July 2017

1 reference

title

Development of pharmacological agents for targeting neurotrophins and their receptors (English)

1 reference

29 July 2017

2

1 reference

29 July 2017

Saragovi HU

1

1 reference

29 July 2017

publication date

1 March 2000

1 reference

Trends in Pharmacological Sciences

29 July 2017

published in

1 reference

29 July 2017

volume

21

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

93-98

1 reference

The Trk family of neurotrophin receptors

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Neurotrophins live or let die: does p75NTR decide?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Regulation of NGF responsiveness in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Small molecule nerve growth factor analogs image receptors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Neurotrophic factor therapy for nervous system degenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

A TrkA-selective, fast internalizing nerve growth factor-antibody complex induces trophic but not neuritogenic signals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Small peptides as potent mimetics of the protein hormone erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Loops and secondary structure mimetics: development and applications in basic science and rational drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Permeability of the blood-brain barrier to neurotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Putrescine-modified nerve growth factor: bioactivity, plasma pharmacokinetics, blood-brain/nerve barrier permeability, and nervous system biodistribution.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Neuroprotection with noninvasive neurotrophin delivery to the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Genuine Monovalent Ligands of TrkA Nerve Growth Factor Receptors Reveal a Novel Pharmacological Mechanism of Action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

PD 90780, a non peptide inhibitor of nerve growth factor's binding to the P75 NGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

The female sex hormone oestrogen as a neuroprotectant

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

The staurosporine-like compound L-753,000 (NB-506) potentiates the neurotrophic effects of neurotrophin-3 by acting selectively at the TrkA receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Nerve growth factor is an autocrine survival factor for memory B lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Pancreatic beta cells synthesize and secrete nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Nerve growth factor suppresses the transforming phenotype of human prolactinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

Topical treatment with nerve growth factor for corneal neurotrophic ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901444-3

7 January 2021

10.1016/S0165-6147(99)01444-3

Identifiers

DOI

1 reference

29 July 2017

1 reference